- Jan 2026
New findings show COVID-19 vaccine reactions in people with MS are generally mild and short-lived.
Latest
- Dec 2025
A look at what we're building for 2026.
New findings show COVID-19 vaccine reactions in people with MS are generally mild and short-lived.
New findings show COVID-19 vaccine reactions in people with MS are generally mild and short-lived.
- Dec 2025
A look at what we're building for 2026.
New findings show COVID-19 vaccine reactions in people with MS are generally mild and short-lived.
We know research matters to you. This month, explore our top articles of the year – featuring the MS-gut connection and other fresh off the press findings in MS research.
- Aug 2025
Not enough time to read an entire newsletter? Our August newsletter snapshot contains the highlights in a quick, easy to read format.
Join an exercise study for wheelchair users, or a clinical trial for people with MS and low mood.